VKTX — Viking Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National
U.S. STOCKS ON THE MOVE-Iron Mountain, BridgeBio, Old Dominion,
U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical
U.S. STOCKS ON THE MOVE-Cisco Systems, Viking Therapeutics, Albemarle
Viking jumps on plans to advance oral obesity drug to late-stage testing
Viking Therapeutics plans to advance oral obesity drug to late-stage testing (updated)
Viking Therapeutics plans to advance oral obesity drug to late-stage trial
Viking Therapeutics rises on plans to test oral obesity drug in late-stage studies
Viking Therapeutics Q4 net loss widens, hurt by higher R&D expenses
Brief: Viking Therapeutics Q4 EPS USD -1.38 Vs. IBES Estimate USD -0.89
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Obesity stocks slump on Novo's underwhelming 2026 sales forecast (updated)
Obesity stocks slump on Novo's underwhelming 2026 sales forecast
US-listed Novo shares slip after company flags sharp 2026 sales drop
Appetite for weight-loss deals broader than visible, Viking CEO says
Structure Therapeutics doubles while other obesity drug developers decline
Factbox: Top pharma companies racing to launch first weight-loss pill
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up